Physical health of patients with severe mental illness: An intervention on medium secure forensic unit

International Journal of Health Care Quality Assurance

Volumn 25, Issue 4, 2012, Pages 363-370

  Vasudev, Kamini ^a   Thakkar, Pratish B ^b   Mitcheson, Nicola ^c  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b Woodside Resource Centre   (United Kingdom)

^c ST NICHOLAS HOSPITAL   (United Kingdom)

Author keywords

Audit; Cardiovascular risk; Forensic; Health services; Intervention; Mental health; Physical health; Risk management

Indexed keywords

LIPID; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; DRUG MONITORING; HEALTH STATUS; HUMAN; LIFESTYLE; MALE; MEDICAL RECORD; MENTAL DISEASE; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; RISK FACTOR; SCHIZOPHRENIA; SMOKING;

ADULT; ANTIPSYCHOTIC AGENTS; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DRUG MONITORING; HEALTH STATUS; HUMANS; LIFE STYLE; LIPIDS; MALE; MEDICAL RECORDS; MENTAL DISORDERS; PILOT PROJECTS; RISK FACTORS; SCHIZOPHRENIA; SMOKING;

EID: 84860371887     PISSN: 09526862     EISSN: None     Source Type: Journal    
DOI: 10.1108/09526861211221527     Document Type: Article

References (23)

1. Auquier, P., Lancon, C., Rouillon, F., Lader, M. and Holmes, C. (2006), "Mortality in schizophrenia" in Pharmacoepidemiology and Drug Safety, Vol. 15, No. 12, pp. 873-9.
2. Barnes, T.R., Paton, C., Cavanagh, M.R., Hancock, E. and Taylor, D.M. (2007), "A UK audit of screening for the metabolic side effects of antipsychotics in community patients" in Schizophrenia Bulletin, Vol. 33, pp. 1397-403.
3. Bushe, C. and Paton, C. (2005), "The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link?" in Journal of Psychopharmacology, Vol. 19, No. 6, pp. 76-83.
4. Canoy, D. (2008), "Distribution of body fat and risk of coronary heart disease in men and women" in Current Opinion in Cardiology, Vol. 23, No. 6, pp. 591-8.
5. Citrome, L. (2005), "Metabolic syndrome and cardiovascular disease" in Journal of Psychopharmacology, Vol. 19, No. 6, pp. 84-93.
6. Cormac, C., Ferriter, M., Benning, R. and Saul, C. (2005), "Physical health and health risk factors in a population of long-stay psychiatric patients" in Psychiatric Bulletin, Vol. 29, pp. 18-20.
7. Cormac, I., Hallford, S., Hart, L., Creasey, S. and Ferriter, M. (2008), "Evaluation of an integrated weight management and fitness programme in a high security psychiatric setting" in Psychiatric Bulletin, Vol. 32, No. 3, pp. 95-8.
8. Feeney, L. and Mooney, M. (2005), "Atypical antipsychotic monitoring in the Kilkenny Mental Health Services" in Irish Journal of Psychological Medicine, Vol. 22, pp. 101-2.
9. Gonzalez, C., Ahammed, N. and Fisher, R. (2010), "Improving physical health monitoring for out-patients on antipsychotic medication" in The Psychiatrist, Vol. 34, pp. 91-4.
10. Haddad, P. (2005), "Weight change with atypical antipsychotics in the treatment of schizophrenia" in Journal of Psychopharmacology, Vol. 19, No. 6, pp. 16-27.
11. Holt, R.I.G., Bushe, C. and Citrome, L. (2005), "Diabetes and schizophrenia: are we any closer to understanding the link?" in Journal of Psychopharmacology, Vol. 19, No. 6, pp. 56-65.
12. Lieberman, J.A., Stroup, T.S., McEvoy, J.P., Swartz, M.S., Rosenheck, R.A. and Perkins, D.O. (2005), "Effectiveness of antipsychotic drugs in patients with chronic schizophrenia" in New England Journal of Medicine, Vol. 353, No. 12, pp. 1209-23.
13. McCreadie, R.G., Scottish Schizophrenia Lifestyle Group (2003), "Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study" in British Journal of Psychiatry, Vol. 183, pp. 534-9.
14. Meiklejohn, C., Sanders, K. and Butler, S. (2003), "Physical health care in medium secure services" in Nursing Standards, Vol. 17, No. 17, pp. 33-7.
15. National Institute for Health and Clinical Excellence (2009), "CG 82 Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care (update)", Clinical Guidelines, National Institute for Health and Clinical Excellence, London.
16. Osborn, D.P., Nazareth, I., Wright, C.A. and King, M.B. (2010), "Impact of nurse-led intervention to improve screening for cardiovascular risk factors in people with severe mental illnesses. Phase-two cluster randomized feasibility trial of community mental health teams" in BMC Health Services Research, Vol. 10, p. 61.
17. Osborn, D.P., Levy, G., Nazareth, I., Petersen, I., Islam, A. and King, M.B. (2007), "Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database" in Archives of General Psychiatry, Vol. 64, pp. 242-9.
18. Osborn, D.P., Wright, C.A., Levy, G., King, M.B., Deo, R. and Nazareth, I. (2008), "Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illness: systematic review and metaanalysis" in BMC Psychiatry, Vol. 8, p. 84.
19. Susce, M.T., Villanueva, N., Diaz, F.J. and de Leon, L. (2005), "Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey" in Journal of Clinical Psychiatry, Vol. 66, pp. 167-73.
20. Tarrant, C.J. (2006), "Blood glucose testing for adults prescribed atypical antipsychotics in primary and secondary care" in Psychiatric Bulletin, Vol. 30, pp. 286-8.
21. Taylor, D., Paton, C. and Kerwin, R. (2007), The Maudsley Prescribing Guidelines, 9th ed., Informa Healthcare, London.
22. Von Hausswolff-Juhlin, Y., Bjartveit, M., Lindstrom, E. and Jones, P. (2009), "Schizophrenia and physical health problems" in Acta Psychiatrica Scandinavica, Vol. 438, pp. 15-21.
23. Wood, D.A., Wray, R., Poulter, N., Williams, B., Kirby, M. and Patel, V. (2005), "JBS2: Joint British guidelines on prevention of cardiovascular disease in clinical practice" in Heart, Vol. 91, pp. V1-V52.